EOLC QIP data.xlsx

Dataset to accompany "Care Beyond Chemotherapy: Using Audit to Improve End-of-Life Care in a Tertiary Cancer Centre".Abstract:(1) Background:<b> </b>Several shortcomings in the delivery of end-of-life care (EoLC) for oncology patients in our centre during the COVID-19 pandemic were identified in our initial 2021 audit. In 2022, we introduced a care of dying patients proforma, EoLC quality checklist, targeted education and training for staff, and an expanded end-of-life (EoL) committee. This re-audit aimed to review how these changes impacted on the care received by our patients.<b> </b>(2)<b> </b>Methods:<b> </b>A second retrospective re-audit of patients who died between 11^th July 2022 and 30^th April 2023, was performed to assess quality of EoLC using the Oxford Quality indicators.<b> </b>(3)<b> </b>Results:<b> </b>72 deaths occurred over the audit period. The mean quality of EoLC was 4.0, compared to 3.5 pre-intervention. Exploration of patients’ wishes was documented in 48.8% and involvement of pastoral care was documented in 68.3%, from 24.2% and 10.6% respectively. The proportion of patients receiving poor EoLC reduced from 21.2% to 8.3%.<b> </b>(4)<b> </b>Conclusions:<b> </b>Our study demonstrates the benefits of simple interventions, the importance of re-audit, and the role of ongoing interdisciplinary commitment to improving EoLC for our patients.